 Treatment of chronic infection in women prior to or during pregnancy does not appear to reduce the probability the disease will be passed on to the infant . Likewise , it is unclear whether prophylactic treatment of chronic infection is beneficial in persons who will undergo immunosuppression ( for example , organ transplant recipients ) or in persons who are already immunosuppressed ( for example , those with HIV infection ) . 
 Treatment of chronic infection in women prior to or during pregnancy <a href='uninflect' title='1'><mark>does</mark></a> not appear to reduce the probability the disease will be passed on to the infant . Likewise , it is unclear whether prophylactic treatment of chronic infection is beneficial in persons <a href='null_relcl' title='2'><mark>who</mark></a>will undergo immunosuppression ( for example , organ transplant recipients ) or in persons who are already immunosuppressed ( for example , those with HIV infection ) . 
Treatment of chronic infection in women prior to or during pregnancy do not appear to reduce da probability tdadisease will b passed on to the infant . Likewise , it is unclear whether prophylactic treatment of chronic infection is beneficial in persons will undergo immunosuppression ( for example , organ transplant recipients ) or in persons who r already immunosuppressed ( for example , those w HIV infection ) .